Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
150M
-
Number of holders
-
218
-
Total 13F shares, excl. options
-
133M
-
Shares change
-
+5.68M
-
Total reported value, excl. options
-
$3.96B
-
Value change
-
+$178M
-
Put/Call ratio
-
3.66
-
Number of buys
-
124
-
Number of sells
-
-109
-
Price
-
$29.52
Significant Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q1 2025
280 filings reported holding RNA - Avidity Biosciences, Inc. - Common Stock as of Q1 2025.
Avidity Biosciences, Inc. - Common Stock (RNA) has 218 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 133M shares
of 150M outstanding shares and own 89.21% of the company stock.
Largest 10 shareholders include FMR LLC (15.6M shares), JANUS HENDERSON GROUP PLC (11.4M shares), PRICE T ROWE ASSOCIATES INC /MD/ (11.3M shares), BlackRock, Inc. (9.92M shares), WELLINGTON MANAGEMENT GROUP LLP (9.68M shares), VANGUARD GROUP INC (9.24M shares), RTW INVESTMENTS, LP (8.75M shares), Avoro Capital Advisors LLC (7.63M shares), RA CAPITAL MANAGEMENT, L.P. (6.3M shares), and STATE STREET CORP (4.32M shares).
This table shows the top 218 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.